These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 7661605

  • 1. Crossover study of thalidomide vs placebo in Jessner's lymphocytic infiltration of the skin.
    Guillaume JC, Moulin G, Dieng MT, Poli F, Morel P, Souteyrand P, Bonnetblanc JM, Claudy A, Daniel F, Vaillant L.
    Arch Dermatol; 1995 Sep; 131(9):1032-5. PubMed ID: 7661605
    [Abstract] [Full Text] [Related]

  • 2. Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis.
    Revuz J, Guillaume JC, Janier M, Hans P, Marchand C, Souteyrand P, Bonnetblanc JM, Claudy A, Dallac S, Klene C.
    Arch Dermatol; 1990 Jul; 126(7):923-7. PubMed ID: 2193629
    [Abstract] [Full Text] [Related]

  • 3. Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: an intergroup study FNCLCC cleo04 IFCT 00-01.
    Pujol JL, Breton JL, Gervais R, Tanguy ML, Quoix E, David P, Janicot H, Westeel V, Gameroff S, Genève J, Maraninchi D.
    J Clin Oncol; 2007 Sep 01; 25(25):3945-51. PubMed ID: 17761978
    [Abstract] [Full Text] [Related]

  • 4. [Sarcoidosis: thalidomide treatment in ten patients].
    Estines O, Revuz J, Wolkenstein P, Bressieux JM, Roujeau JC, Cosnes A.
    Ann Dermatol Venereol; 2001 May 01; 128(5):611-3. PubMed ID: 11427794
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of Jessner-Kanof disease with thalidomide].
    Moulin G, Bonnet F, Barrut D, Franc MP.
    Ann Dermatol Venereol; 1983 May 01; 110(8):611-4. PubMed ID: 6362525
    [Abstract] [Full Text] [Related]

  • 6. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study.
    Miehlke S, Madisch A, Karimi D, Wonschik S, Kuhlisch E, Beckmann R, Morgner A, Mueller R, Greinwald R, Seitz G, Baretton G, Stolte M.
    Gastroenterology; 2009 Jun 01; 136(7):2092-100. PubMed ID: 19303012
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun 01; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 8. Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma.
    Tosi P, Zamagni E, Cellini C, Ronconi S, Patriarca F, Ballerini F, Musto P, Di Raimondo F, Ledda A, Lauria F, Masini L, Gobbi M, Vacca A, Ria R, Cangini D, Tura S, Baccarani M, Cavo M.
    Haematologica; 2002 Apr 01; 87(4):408-14. PubMed ID: 11940485
    [Abstract] [Full Text] [Related]

  • 9. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM, Messina J, Xie F, Hale M.
    Clin Ther; 2007 Apr 01; 29(4):588-601. PubMed ID: 17617282
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 01; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 11. Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease.
    Chao NJ, Parker PM, Niland JC, Wong RM, Dagis A, Long GD, Nademanee AP, Negrin RS, Snyder DS, Hu WW, Gould KA, Tierney DK, Zwingenberger K, Forman SJ, Blume KG.
    Biol Blood Marrow Transplant; 1996 May 01; 2(2):86-92. PubMed ID: 9118303
    [Abstract] [Full Text] [Related]

  • 12. [Low-dose thalidomide in refractory and relapsing multiple myeloma].
    Radocha J, Maisnar V.
    Vnitr Lek; 2007 Feb 01; 53(2):129-34. PubMed ID: 17419173
    [Abstract] [Full Text] [Related]

  • 13. Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial.
    Drenth JP, Vonk AG, Simon A, Powell R, van der Meer JW.
    J Pharmacol Exp Ther; 2001 Sep 01; 298(3):1221-6. PubMed ID: 11504824
    [Abstract] [Full Text] [Related]

  • 14. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS, Kirby L, Kumar D, Cullen EI, Pratt RD, Hahne WA.
    Br J Clin Pharmacol; 2004 Nov 01; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
    Kress HG, Orońska A, Kaczmarek Z, Kaasa S, Colberg T, Nolte T.
    Clin Ther; 2009 Jun 01; 31(6):1177-91. PubMed ID: 19695386
    [Abstract] [Full Text] [Related]

  • 16. Thalidomide as therapy for human immunodeficiency virus-related oral ulcers: a double-blind placebo-controlled clinical trial.
    Ramirez-Amador VA, Esquivel-Pedraza L, Ponce-de-Leon S, Reyes-Teran G, Gonzalez-Guevara M, Ponce-de-Leon S, Sierra-Madero JG.
    Clin Infect Dis; 1999 Apr 01; 28(4):892-4. PubMed ID: 10825055
    [Abstract] [Full Text] [Related]

  • 17. Neuropathy in multiple myeloma treated with thalidomide: a prospective study.
    Plasmati R, Pastorelli F, Cavo M, Petracci E, Zamagni E, Tosi P, Cangini D, Tacchetti P, Salvi F, Bartolomei I, Michelucci R, Tassinari CA.
    Neurology; 2007 Aug 07; 69(6):573-81. PubMed ID: 17679676
    [Abstract] [Full Text] [Related]

  • 18. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U.
    J Neurol; 2003 Mar 07; 250(3):347-51. PubMed ID: 12638027
    [Abstract] [Full Text] [Related]

  • 19. A prospective double-blind, placebo-controlled study of thalidomide sensory symptoms in an elderly population with age-related macular degeneration.
    Souayah N, Khella SL.
    J Clin Neurosci; 2010 May 07; 17(5):571-3. PubMed ID: 20223672
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial.
    Hulin C, Facon T, Rodon P, Pegourie B, Benboubker L, Doyen C, Dib M, Guillerm G, Salles B, Eschard JP, Lenain P, Casassus P, Azaïs I, Decaux O, Garderet L, Mathiot C, Fontan J, Lafon I, Virion JM, Moreau P.
    J Clin Oncol; 2009 Aug 01; 27(22):3664-70. PubMed ID: 19451428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.